These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10362049)

  • 21. Antimicrobial management of acute exacerbation of chronic airflow limitation.
    Davies L; Hadcroft J; Mutton K; Earis JE; Kennedy N
    QJM; 2001 Jul; 94(7):373-8. PubMed ID: 11435633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amoxycillin/potassium clavulanate (augmentin)--current importance in the treatment of infection].
    Fomina IP
    Antibiot Khimioter; 1997; 42(9):36-43. PubMed ID: 9412419
    [No Abstract]   [Full Text] [Related]  

  • 23. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Miravitlles M; Llor C; Naberan K; Cots JM; Molina J;
    Respir Med; 2005 Aug; 99(8):955-65. PubMed ID: 15950136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotics in acute exacerbations of COPD: the good, the bad and the ugly.
    Boersma WG
    Eur Respir J; 2012 Jul; 40(1):1-3. PubMed ID: 22753830
    [No Abstract]   [Full Text] [Related]  

  • 25. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
    Rosón B; Carratalà J; Tubau F; Dorca J; Liñares J; Pallares R; Manresa F; Gudiol F
    Microb Drug Resist; 2001; 7(1):85-96. PubMed ID: 11310807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of amoxycillin/clavulanate with amoxycillin in children and adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae.
    Jensen T; Pedersen SS; Stafanger G; Høiby N; Koch C; Bondesson G
    Scand J Infect Dis; 1988; 20(5):517-24. PubMed ID: 3065925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
    Anthonisen NR; Manfreda J; Warren CP; Hershfield ES; Harding GK; Nelson NA
    Ann Intern Med; 1987 Feb; 106(2):196-204. PubMed ID: 3492164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patient.
    Murphy TF; Sethi S
    Drugs Aging; 2002; 19(10):761-75. PubMed ID: 12390053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of anaerobic bacteria in community-acquired respiratory pathology].
    Dubreuil L
    Presse Med; 1998 Sep; 27 Suppl 4():10-1. PubMed ID: 9798476
    [No Abstract]   [Full Text] [Related]  

  • 30. Relation between beta-lactamase producing bacteria and patient characteristics in chronic obstructive pulmonary disease (COPD).
    Sportel JH; Koëter GH; van Altena R; Löwenberg A; Boersma WG
    Thorax; 1995 Mar; 50(3):249-53. PubMed ID: 7660337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease.
    Llor C; Moragas A; Hernández S; Bayona C; Miravitlles M
    Am J Respir Crit Care Med; 2012 Oct; 186(8):716-23. PubMed ID: 22923662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.
    Stockley RA; O'Brien C; Pye A; Hill SL
    Chest; 2000 Jun; 117(6):1638-45. PubMed ID: 10858396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
    Herath SC; Poole P
    Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Once-a-day therapy for sinusitis: a comparison study of cefixime and amoxicillin.
    Edelstein DR; Avner SE; Chow JM; Duerksen RL; Johnson J; Ronis M; Rybak LP; Bierman WC; Matthews BL; Kohlbrenner VM
    Laryngoscope; 1993 Jan; 103(1 Pt 1):33-41. PubMed ID: 8421417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
    Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three vs. 10 days of amoxycillin-clavulanic acid for type 1 acute exacerbations of chronic obstructive pulmonary disease: a randomised, double-blind study.
    Roede BM; Bresser P; El Moussaoui R; Krouwels FH; van den Berg BT; Hooghiemstra PM; de Borgie CA; Speelman P; Bossuyt PM; Prins JM
    Clin Microbiol Infect; 2007 Mar; 13(3):284-90. PubMed ID: 17391383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment effects of co-amoxiclav (Amoxiclav 2x) in acute exacerbation of severe chronic obstructive pulmonary disease: clinical evaluation].
    Andrijević I; Povazan D; Andrijević L; Povazan A; Milutinov S
    Med Pregl; 2011; 64(3-4):178-82. PubMed ID: 21905596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.
    Wilson R; Anzueto A; Miravitlles M; Arvis P; Haverstock D; Trajanovic M; Sethi S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():985-93. PubMed ID: 26082623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD.
    Adams SG; Melo J; Luther M; Anzueto A
    Chest; 2000 May; 117(5):1345-52. PubMed ID: 10807821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Management of community-acquired pneumopathies of adults in the city and at the hospital].
    Léophonte P
    Presse Med; 1998 Sep; 27 Suppl 4():5-7. PubMed ID: 9798473
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.